Welcome to LookChem.com Sign In|Join Free
  • or
4-(4,6-dimethylpyrimidin-2-yl)morpholine is a chemical compound with the molecular formula C10H14N2O. It is a derivative of morpholine, a heterocyclic organic compound, and features a pyrimidin-2-yl group at the 4-position. The pyrimidin-2-yl group itself has two methyl groups at the 4 and 6 positions, which contribute to the compound's structure and properties. 4-(4,6-dimethylpyrimidin-2-yl)morpholine is known for its potential applications in the pharmaceutical industry, particularly as a building block for the synthesis of various drugs. Its unique structure allows it to form part of complex molecules that can interact with biological targets, making it a valuable intermediate in medicinal chemistry.

7749-51-1

Post Buying Request

7749-51-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7749-51-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7749-51-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,7,4 and 9 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 7749-51:
(6*7)+(5*7)+(4*4)+(3*9)+(2*5)+(1*1)=131
131 % 10 = 1
So 7749-51-1 is a valid CAS Registry Number.

7749-51-1Downstream Products

7749-51-1Relevant academic research and scientific papers

Heat shock protein 70 inhibitors. 1. 2,5′-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides as irreversible binders to an allosteric site on heat shock protein 70

Kang, Yanlong,Taldone, Tony,Patel, Hardik J.,Patel, Pallav D.,Rodina, Anna,Gozman, Alexander,Maharaj, Ronnie,Clement, Cristina C.,Patel, Maulik R.,Brodsky, Jeffrey L.,Young, Jason C.,Chiosis, Gabriela

, p. 1188 - 1207 (2014/03/21)

Heat shock protein 70 (Hsp70) is an important emerging cancer target whose inhibition may affect multiple cancer-associated signaling pathways and, moreover, result in significant cancer cell apoptosis. Despite considerable interest from both academia and

NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF

-

Page/Page column 153-154, (2010/12/29)

A compound represented by the formula (I): wherein each symbol is as defined in the specification, and a salt thereof have a GPR40 receptor activation action and is useful as an insulin secretagogue or a prophylactic or therapeutic drug for diabetes and the like.

Substituted pyrimidine derivatives

-

Page/Page column 13, (2008/06/13)

The present invention relates to pyrimidine derivatives of the general formula I or salts thereof and their use.

PYRIMIDINE DERIVATIVES AND THEIR USE AS KCNQ POTASSIUM CHANNELS OPENERS

-

Page/Page column 31, (2008/06/13)

The present invention relates to pyrimidine derivatives of the general formula I or salts thereof and their use as openers of the KNCQ family potassium ion channels, particularly in the treatment of epilepsy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7749-51-1